AbCellera to Report Third Quarter 2022 Financial Results on November 8, 2022
AbCellera (Nasdaq: ABCL) will release its third quarter 2022 financial results on November 8, 2022, followed by an earnings call at 2:00 p.m. PT. The call will be accessible via a live audio webcast on AbCellera’s Investor Relations website. AbCellera specializes in analyzing natural immune systems to discover antibodies for drug development, partnering with a wide array of drug developers to enhance efficiency and tackle complex challenges in the industry.
- Strong partnerships with diverse drug developers, enhancing drug development efficiency.
- None.
A live audio webcast of the earnings conference may be accessed through a link that will be posted on AbCellera’s Investor Relations website. A replay will be available through the same link following the conference call.
About
AbCellera is a technology company that searches, decodes, and analyzes natural immune systems to find antibodies that its partners can develop into drugs to prevent and treat disease. AbCellera partners with drug developers of all sizes, from large pharmaceutical to small biotechnology companies, empowering them to move quickly, reduce cost, and tackle the toughest problems in drug development. For more information, please visit www.abcellera.com.
Source:
View source version on businesswire.com: https://www.businesswire.com/news/home/20221011006080/en/
Inquiries
Media:
Business Development:
Investor Relations:
Source:
FAQ
When will AbCellera announce its third quarter 2022 financial results?
What time is AbCellera's earnings conference call?
Where can I access the audio webcast for AbCellera's earnings call?
What does AbCellera specialize in?
What is AbCellera's stock symbol?
